Clinical Trial Update: GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/Phase 2 clinical trial update for GAIA-102 delivered intraperitoneally in patients with advanced microsatellite-stable gastrointestinal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• GAIA-102

Snippet

Sponsor: Kyushu University | Conditions: Gastric Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING